vs

Side-by-side financial comparison of Chemours Co (CC) and AMDOCS LTD (DOX). Click either name above to swap in a different company.

Chemours Co is the larger business by last-quarter revenue ($1.3B vs $1.3B, roughly 1.1× AMDOCS LTD). AMDOCS LTD runs the higher net margin — 11.2% vs -3.5%, a 14.8% gap on every dollar of revenue. On growth, AMDOCS LTD posted the faster year-over-year revenue change (1.1% vs -2.1%). Over the past eight quarters, AMDOCS LTD's revenue compounded faster (4.5% CAGR vs -1.2%).

The Chemours Company is an American chemical company that was founded in July 2015 as a spin-off from DuPont. It has its corporate headquarters in Wilmington, Delaware, United States. Chemours is the manufacturer of Teflon, the brand name of polytetrafluoroethylene (PTFE), known for its anti-stick properties. It also produces titanium dioxide and refrigerant gases.

Amdocs Limited is a multinational telecommunications technology company headquartered in Chesterfield, Missouri. The company specializes in software and services for communications, media and financial services providers and digital enterprises. Amdocs was founded in 1982 and is publicly traded on the Nasdaq stock exchange.

CC vs DOX — Head-to-Head

Bigger by revenue
CC
CC
1.1× larger
CC
$1.3B
$1.3B
DOX
Growing faster (revenue YoY)
DOX
DOX
+3.2% gap
DOX
1.1%
-2.1%
CC
Higher net margin
DOX
DOX
14.8% more per $
DOX
11.2%
-3.5%
CC
Faster 2-yr revenue CAGR
DOX
DOX
Annualised
DOX
4.5%
-1.2%
CC

Income Statement — Q4 FY2025 vs Q3 FY2024

Metric
CC
CC
DOX
DOX
Revenue
$1.3B
$1.3B
Net Profit
$-47.0M
$140.3M
Gross Margin
11.7%
Operating Margin
14.1%
Net Margin
-3.5%
11.2%
Revenue YoY
-2.1%
1.1%
Net Profit YoY
-261.5%
-12.0%
EPS (diluted)
$-0.32
$1.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CC
CC
DOX
DOX
Q4 25
$1.3B
Q3 25
$1.5B
Q2 25
$1.6B
Q1 25
$1.4B
Q4 24
$1.4B
Q3 24
$1.5B
Q2 24
$1.6B
$1.3B
Q1 24
$1.4B
$1.2B
Net Profit
CC
CC
DOX
DOX
Q4 25
$-47.0M
Q3 25
$46.0M
Q2 25
$-380.0M
Q1 25
$-5.0M
Q4 24
$-13.0M
Q3 24
$-32.0M
Q2 24
$60.0M
$140.3M
Q1 24
$54.0M
$118.5M
Gross Margin
CC
CC
DOX
DOX
Q4 25
11.7%
Q3 25
15.6%
Q2 25
17.2%
Q1 25
17.3%
Q4 24
19.4%
Q3 24
19.0%
Q2 24
19.8%
Q1 24
20.9%
Operating Margin
CC
CC
DOX
DOX
Q4 25
Q3 25
2.5%
Q2 25
-15.4%
Q1 25
Q4 24
-0.1%
Q3 24
-2.1%
Q2 24
4.4%
14.1%
Q1 24
5.1%
12.5%
Net Margin
CC
CC
DOX
DOX
Q4 25
-3.5%
Q3 25
3.1%
Q2 25
-23.5%
Q1 25
-0.4%
Q4 24
-1.0%
Q3 24
-2.1%
Q2 24
3.9%
11.2%
Q1 24
4.0%
9.5%
EPS (diluted)
CC
CC
DOX
DOX
Q4 25
$-0.32
Q3 25
$0.31
Q2 25
$-2.53
Q1 25
$-0.03
Q4 24
$-0.07
Q3 24
$-0.22
Q2 24
$0.39
$1.21
Q1 24
$0.36
$1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CC
CC
DOX
DOX
Cash + ST InvestmentsLiquidity on hand
$670.0M
Total DebtLower is stronger
$4.1B
Stockholders' EquityBook value
$250.0M
Total Assets
$7.4B
Debt / EquityLower = less leverage
16.40×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CC
CC
DOX
DOX
Q4 25
$670.0M
Q3 25
$613.0M
Q2 25
$502.0M
Q1 25
$464.0M
Q4 24
$713.0M
Q3 24
$596.0M
Q2 24
$604.0M
Q1 24
$746.0M
Total Debt
CC
CC
DOX
DOX
Q4 25
$4.1B
Q3 25
$4.1B
Q2 25
$4.1B
Q1 25
$4.1B
Q4 24
$4.1B
Q3 24
$4.0B
Q2 24
$4.0B
Q1 24
$4.0B
Stockholders' Equity
CC
CC
DOX
DOX
Q4 25
$250.0M
Q3 25
$274.0M
Q2 25
$228.0M
Q1 25
$566.0M
Q4 24
$571.0M
Q3 24
$643.0M
Q2 24
$714.0M
Q1 24
$753.0M
Total Assets
CC
CC
DOX
DOX
Q4 25
$7.4B
Q3 25
$7.5B
Q2 25
$7.5B
Q1 25
$7.4B
Q4 24
$7.5B
Q3 24
$7.5B
Q2 24
$7.2B
Q1 24
$8.0B
Debt / Equity
CC
CC
DOX
DOX
Q4 25
16.40×
Q3 25
14.96×
Q2 25
17.99×
Q1 25
7.18×
Q4 24
7.11×
Q3 24
6.20×
Q2 24
5.53×
Q1 24
5.27×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CC
CC
DOX
DOX
Operating Cash FlowLast quarter
$137.0M
Free Cash FlowOCF − Capex
$92.0M
FCF MarginFCF / Revenue
6.9%
Capex IntensityCapex / Revenue
3.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$51.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CC
CC
DOX
DOX
Q4 25
$137.0M
Q3 25
$146.0M
Q2 25
$93.0M
Q1 25
$-112.0M
Q4 24
$138.0M
Q3 24
$139.0M
Q2 24
$-620.0M
Q1 24
$-290.0M
Free Cash Flow
CC
CC
DOX
DOX
Q4 25
$92.0M
Q3 25
$105.0M
Q2 25
$50.0M
Q1 25
$-196.0M
Q4 24
$29.0M
Q3 24
$63.0M
Q2 24
$-693.0M
Q1 24
$-392.0M
FCF Margin
CC
CC
DOX
DOX
Q4 25
6.9%
Q3 25
7.0%
Q2 25
3.1%
Q1 25
-14.3%
Q4 24
2.1%
Q3 24
4.2%
Q2 24
-44.6%
Q1 24
-28.8%
Capex Intensity
CC
CC
DOX
DOX
Q4 25
3.4%
Q3 25
2.7%
Q2 25
2.7%
Q1 25
6.1%
Q4 24
8.0%
Q3 24
5.0%
Q2 24
4.7%
Q1 24
7.5%
Cash Conversion
CC
CC
DOX
DOX
Q4 25
Q3 25
3.17×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-10.33×
Q1 24
-5.37×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CC
CC

Titanium Technologies$563.0M42%
Thermal And Specialized Solutions$443.0M33%
Advanced Performance Materials$312.0M23%
Other Non-Reportable Segment$12.0M1%

DOX
DOX

Segment breakdown not available.

Related Comparisons